Return to Issue Details SAFETY PROFILE AND ADVERSE EVENTS ASSOCIATED WITH GLP-1/GIP RECEPTOR AGONISTS IN NON-DIABETIC INDIVIDUALS WITH OVERWEIGHT OR OBESITY: AN INTEGRATIVE REVIEW Download Download PDF